Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

WS Titamax Impl Ti 4.0X5: medical device reports filed with FDA

318 reports name it, 2020–2026. Manufacturer given most often on reports: Jjgc. Product code DZE.

318
device reports naming the brand
0% of all MAUDE reports · about 52 a year
44
reports, 12 months to August 2026
49 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

318 medical device reports received by FDA name the brand "WS Titamax Impl Ti 4.0X5" (endosseous dental implant); the manufacturer given most often on reports is Jjgc; received from May 2020 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

44 reports arrived in the 12 months to August 2026, down 10% from 49 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (63.8%), loss of osseointegration (26.4%) and insufficient device problem information (1.6%). The patient problems coded most often are pain, failure of implant and tissue damage. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

0714Sep 2021: 2Oct 2021: 3Nov 2021: 3Dec 2021: 32022Jan 2022: 6Feb 2022: 7Mar 2022: 6Apr 2022: 0May 2022: 6Jun 2022: 3Jul 2022: 8Aug 2022: 7Sep 2022: 2Oct 2022: 3Nov 2022: 6Dec 2022: 32023Jan 2023: 4Feb 2023: 4Mar 2023: 5Apr 2023: 6May 2023: 7Jun 2023: 3Jul 2023: 5Aug 2023: 6Sep 2023: 0Oct 2023: 2Nov 2023: 9Dec 2023: 02024Jan 2024: 9Feb 2024: 8Mar 2024: 1Apr 2024: 0May 2024: 5Jun 2024: 9Jul 2024: 4Aug 2024: 3Sep 2024: 5Oct 2024: 3Nov 2024: 11Dec 2024: 22025Jan 2025: 5Feb 2025: 1Mar 2025: 4Apr 2025: 1May 2025: 0Jun 2025: 14Jul 2025: 0Aug 2025: 3Sep 2025: 3Oct 2025: 3Nov 2025: 1Dec 2025: 32026Jan 2026: 5Feb 2026: 4Mar 2026: 9Apr 2026: 0May 2026: 5Jun 2026: 3Jul 2026: 3Aug 2026: 5

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

030602020: 3920202021: 3920212022: 5720222023: 5120232024: 6020242025: 3820252026: 342026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%318
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report99.7%317
Voluntary report0%0
User facility report0%0
Distributor report0.3%1
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate20363.8%62.8%
Loss of osseointegration8426.4%22.4%
Insufficient device problem information51.6%0.2%
Difficult to insertthe device was hard to insert30.9%0.4%
Fracturea broken bone20.6%1.6%
Osseointegration problem10.3%7.7%
Separation failure10.3%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Painpain, site not specified6420.1%
Failure of implant299.1%
Tissue damage216.6%
Swelling/ edema165%
Fibrosis144.4%
Fistula123.8%
Inflammationinflammation103.1%
Abscessa collection of pus51.6%
Hypersensitivity/allergic reaction41.3%
Inadequate osseointegration30.9%
Hemorrhage/blood loss/bleeding20.6%
Hyperresponsive to stimuli20.6%
Sinus perforation20.6%
Bone fracture(s)10.3%
Loss of range of motion10.3%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureWS Titamax Impl Ti 4.0X5Product code DZEAll MAUDE reports
Reports3183,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer99.7%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about WS Titamax Impl Ti 4.0X5 reports

How many FDA reports name WS Titamax Impl Ti 4.0X5?

318 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 44 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (63.8%), loss of osseointegration (26.4%), insufficient device problem information (1.6%), difficult to insert (0.9%) and fracture (0.6%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (99.7%) and distributor reports (0.3%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that WS Titamax Impl Ti 4.0X5 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.